The neuroprotective effects of RAS inhibitors (ACEI or ARB) on the peripheral nervous system, observed in mouse models of peripheral neuropathy, are believed to be mediated by a shift in the RAS cascade from AT1R to angiotensin II type 2 receptor (AT2R) [29]. This evidence concerns the gene AGTR2 and peripheral neuropathy.